Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients

Universitaire Ziekenhuizen KU Leuven

Status: Completed

Conditions: Gram-Positive Bacterial Infections

Treatments: Other: Plasma exposure vancomycin

Study type: Observational

Funder types: Other

Identifiers

NCT03560440

S56779

Details and patient eligibility

About

In this retrospective registry the investigators wish to verify whether the current dosing regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric patients. Therefore data will be collected from all pediatric patients hospitalized in University Hospitals Leuven between January 2012 and April 2014 who were treated with vancomycine.

Full description

In this retrospective registry the investigators wish to verify whether the current dosing regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric patients. Therefore data will be collected from all pediatric patients hospitalized in University Hospitals Leuven between January 2012 and April 2014 who were treated with vancomycine. Patient files will be screened for relevant information. Individual patients can be included multiple times if vancomycin has been administered more than once.

Enrollment: 368 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pediatric patients hospitalized in the University Hospitals Leuven between January 2012 and April 2014, treated with vancomycin

Exclusion criteria

Trial design

368 participants in 1 patient group

Plasma exposure vancomycin

Description:

Pediatric patients treated with vancomycin

Treatment:

Other: Plasma exposure vancomycin